Log In
BCIQ
Print this Print this
 

alitretinoin (Panretin Gel)

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionTopical 0.1% 9-cis-retinoic acid gel
Molecular Target Retinoic acid receptor (RAR)
Mechanism of ActionRetinoic acid receptor (RAR) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationKaposi's sarcoma
Indication DetailsTreat AIDS-related Kaposi's sarcoma (KS); Treat Kaposi's sarcoma (KS)
Regulatory Designation U.S. - Orphan Drug (Treat AIDS-related Kaposi's sarcoma (KS))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today